omni
aaps
Martin Shkreli's Trial Shows Just How Angry People Are About Drug Prices
Martin Shkreli's Trial Shows Just How Angry People Are About Drug Prices
Martin Shkreli isn't actually on trial for buying an obscure antiparasitic drug used by AIDS patients and jacking up the price astronomically, but he might as well be.
US FDA Sounds Alert On Quality Issues in Indian Pharma
US FDA Sounds Alert On Quality Issues in Indian Pharma
Quality is a challenge for the Indian pharmaceutical sector, the largest supplier of drugs to the United States, according to a recent blog by the U.S. Food and Drug Administration.
FDA Asks Teva Pharmaceutical For Further Study On Huntington's Drug
FDA Asks Teva Pharmaceutical For Further Study On Huntington's Drug
Approval for Israel-based Teva Pharmaceutical Industries' drug to treat the neurological disorder chorea has been held up by U.S. regulators seeking further blood studies, the company said.
Tackling the Prior Authorization Challenge: A Critical Task for Pharma
Tackling the Prior Authorization Challenge: A Critical Task for Pharma
Talk with busy physicians and you'll soon hear about the ever-increasing difficulty in getting approval for the medications that they believe are most appropriate for their patients.
Groups Challenge Explanation of Drug Price Cap Initiative
Groups Challenge Explanation of Drug Price Cap Initiative
Industry groups have filed a court challenge to the South Dakota attorney general's explanation of a ballot question that would cap how much state agencies could pay for prescription drugs.